Psychedelic Research Recap April 2022
Over the month of April, we continued to learn more about psychedelic medicine as we added over 80 papers to our database. Here you’ll find a recap of of the most significant publications.
Over the month of April, we continued to learn more about psychedelic medicine as we added over 80 papers to our database. Here you’ll find a recap of of the most significant publications.
Psychedelic research in April pitted psychedelics against SSRIs, gave mice a break from tripping, and found new psychedelics. As we’re awaiting the full results of the MAPS Phase III MDMA trial data, let’s look back at the research of last month.